Anti-SARS-CoV-2 Spike Antibody Response to the Fourth Dose of BNT162b2 mRNA COVID-19 Vaccine and Associated Factors in Japanese Hemodialysis Patients.
Keiji HiraiMasako ShimotashiroToshiaki OkumuraSusumu OokawaraYoshiyuki MorishitaPublished in: International journal of nephrology and renovascular disease (2024)
Hypoxia-inducible factor prolyl hydroxylase inhibitor use and the anti-SARS-CoV-2 spike antibody titer before the fourth dose were associated with the anti-SARS-CoV-2 spike antibody titer after the fourth dose in Japanese hemodialysis patients.
Keyphrases